Abstract LB030: A novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19
Ki Hyun Kim(Chonnam National University Hwasun Hospital), Marco Ruella(Parker Institute for Cancer Immunotherapy), Ruchi P. Patel(University of Pennsylvania), Bong-Kook Ko, Gae-Baik Kim, Soohwan Kim(Dong-A University), Min Yoon, Jong-Seo Lee(Advanced Biomass R&D Center (South Korea)), LeiGuang Cui, Junho Chung(Cancer Research Institute), Youngha Lee(University of Pennsylvania), Soohyun Kim(Korea Basic Science Institute), Jongho Lee(Seoul National University), Sung‐Min Kim(Dong-A University), Ji‐Ho Park(Korea Advanced Institute of Science and Technology), Hyun‐Jong Lee, Ji-Hyeon Choi, Yong Gu Lee(Parker Institute for Cancer Immunotherapy), In-Sik Hwang, Guewha Lee
Cited by 1
Related Papers
GABA-modulating bacteria of the human gut microbiota
|Nature Microbiology|2018|1.1k
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
|Journal of Clinical Investigation|2016|554
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast
|Proceedings of the National Academy of Sciences|2010|433